Test Overview
Test Methodology

Chemiluminescent Immunoassay

Test Usage

For detection of IgG and IgM antibodies to Borrelia burgdorferi. If clinical symptoms are present, a positive test result supports the diagnosis of Lyme Disease.

Reference Range *

Negative

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Limitations

A positive test result in the absence of clinical symptoms may be due to cross-reactivity with antibodies to non-pathogenic treponemes, infectious mononucleosis and from auto-immune disease.

Test Details
Days Set Up
Monday - Friday
Analytic Time

8 hours

Soft Order Code
BORSC
MiChart Code
Borrelia (Lyme Disease) Screen, Total AB; Borreilia (Lyme Disease) Confirmation, IGG or IGM
Synonyms
  • Lyme Disease Antibody
  • Borrelia burgdorferi Antibody
  • Lyme Disease Index
  • Tick Borne Disease
Laboratory
Chemical Pathology
Section
Special Chemistry
Specimen Requirements
Collection Instructions

Collect specimen in an SST (preferred) or red top tube. Centrifuge, aliquot serum into a plastic vial and refrigerate.

Normal Volume
1 mL serum
Minimum Volume
0.3 mL serum
Additional Information

Any specimen that gives a positive or equivocal result for the Borrelia burgdorferi screen test will have in-house Lyme IGG and Lyme IGM confirmatory testing at an additional charge. By ordering this test the clinician acknowledges that additional reflex testing will be performed and billed at a separate additional charge if indicated. If the patient is diagnosed with Lyme disease and the immunoassay result is negative, it is recommended that a repeat specimen be sent in 6 weeks.

Billing
CPT Code
86618
Fee Code
37954
Reflex CPT
86617 x2
Reflex Fee Code
VA001, VA002
LOINC
20449-5; 40612-4; 16480-6
NY State Approved
No